Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Garnier hired to restructure French firm
What's GlaxoSmithKline's ex-CEO Jean-Pierre Garnier up to these days? Well, in addition to director and advisory roles he holds at United Technologies, Renault, and the sovereign fund Dubai Capital, Garnier is expected to "return to his French roots" as chief executive of the health and beauty company Pierre Fabre.
As you know, Garnier retired from GSK in May, leaving new CEO Andrew Witty in charge. His mandate at Fabre, the Financial Times reports, will be the restructuring of the company, which is located in southwest France. Garnier has plenty of experience at overhauls: He engineered a big one, with thousands of layoffs, just before turning over GSK's reins to Witty.
- see the FT story
Related Articles:
GSK's Garnier: FDA raised the bar for new drugs
GSK's Garnier gets $4.9M handshake
'No regrets,' says newly retired JP Garnier
GSK's Garnier to join Dubai equity firm
GSK taps Witty as next CEO
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
